Enanta Pharmaceuticals (ENTA) Q3 2025 Earnings

11AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.36
-1.19
-1.02
-0.85

Details

Expected EPS
-0.9
Actual EPS
-0.85
Surprise EPS
0.05
Surprise Percent
+5.56%

Description

Enanta Pharmaceuticals (ENTA) has reported earnings of -0.85 per share for Q3 2025.

0 Comments

Share your thoughts